13F HOLDINGS REPORT
TCG Crossover Management, LLC
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0001214659-25-002888
Total Value
$1.02B
Positions
38
Other Managers
0
Confidential Omitted
No
Holdings (38)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | CG ONCOLOGY INC | CGON | 3,670,206 | $105.3M | 10.29% |
| 2 | DYNE THERAPEUTICS INC | DYN | 2,650,150 | $62.4M | 6.10% |
| 3 | XENCOR INC | XNCR | 2,452,138 | $56.4M | 5.51% |
| 4 | COGENT BIOSCIENCES INC | COGT | 6,964,375 | $54.3M | 5.31% |
| 5 | CENTESSA PHARMACEUTICALS PLC | CNTA | 2,890,816 | $48.4M | 4.73% |
| 6 | OCULAR THERAPEUTIX INC | OCUL | 5,319,148 | $45.4M | 4.44% |
| 7 | UPSTREAM BIO INC | UPB | 2,801,763 | $44.9M | 4.38% |
| 8 | ABIVAX SA AMERICAN DEPOSITARY SHARES | AAVXF | 6,056,596 | $44.3M | 4.33% |
| 9 | SAVARA INC | SVRA | 12,362,205 | $38.0M | 3.71% |
| 10 | TANGO THERAPEUTICS INC | TNGX | 10,736,000 | $33.2M | 3.24% |
| 11 | DIANTHUS THERAPEUTICS INC | DNTH | 1,501,624 | $32.7M | 3.20% |
| 12 | DISC MEDICINE INC | IRON | 486,957 | $30.9M | 3.02% |
| 13 | MINERALYS THERAPEUTICS INC | MLYS | 2,470,265 | $30.4M | 2.97% |
| 14 | TOURMALINE BIO INC | 89157D105 | 1,477,593 | $30.0M | 2.93% |
| 15 | STRUCTURE THERAPEUTICS INC | GPCR | 1,063,000 | $28.8M | 2.82% |
| 16 | TYRA BIOSCIENCES INC | TYRA | 1,989,103 | $27.6M | 2.70% |
| 17 | EYEPOINT PHARMACEUTICALS INC | EYPT | 3,572,335 | $26.6M | 2.60% |
| 18 | Cidara Therapeutics, Inc. | 171757206 | 1,005,901 | $26.1M | 2.55% |
| 19 | THIRD HARMONIC BIO INC | 88427A107 | 2,505,424 | $25.8M | 2.52% |
| 20 | SOLENO THERAPEUTICS INC | SLNO | 550,000 | $24.7M | 2.42% |
| 21 | ASTRIA THERAPEUTICS INC | 04635X102 | 2,761,861 | $24.7M | 2.41% |
| 22 | FULCRUM THERAPEUTICS INC | FULC | 5,250,000 | $24.7M | 2.41% |
| 23 | SILENCE THERAPEUTICS PLC | SLNCF | 3,033,560 | $20.9M | 2.04% |
| 24 | RAPT Therapeutics, Inc. | 75382E109 | 13,135,260 | $19.8M | 1.93% |
| 25 | AMYLYX PHARMACEUTICALS INC | AMLX | 4,643,812 | $17.6M | 1.72% |
| 26 | COMPASS PATHWAYS LTD | CMPS | 3,858,000 | $14.6M | 1.43% |
| 27 | KURA ONCOLOGY INC | KURA | 1,423,642 | $12.4M | 1.21% |
| 28 | MBX BIOSCIENCES INC | MBX | 650,000 | $12.0M | 1.17% |
| 29 | KODIAK SCIENCES INC | KOD | 1,145,538 | $11.4M | 1.11% |
| 30 | ENTRADA THERAPEUTICS INC | TRDA | 584,955 | $10.1M | 0.99% |
| 31 | KEROS THERAPEUTICS INC | KROS | 550,000 | $8.7M | 0.85% |
| 32 | ADVERUM BIOTECHNOLOGIES INC | 00773U207 | 1,796,482 | $8.4M | 0.82% |
| 33 | VISTAGEN THERAPEUTICS INC | VTGN | 2,676,580 | $7.9M | 0.77% |
| 34 | AEROVATE THERAPEUTICS INC | 008064107 | 2,240,809 | $5.9M | 0.58% |
| 35 | NEKTAR THERAPEUTICS | NKTR | 4,000,000 | $3.7M | 0.36% |
| 36 | AVALO THERAPEUTICS INC | AVTX | 483,000 | $3.6M | 0.35% |
| 37 | VENTYX BIOSCIENCES INC | 92332V107 | 316,195 | $692,467 | 0.07% |
| 38 | CABALETTA BIO INC | CABA | 86,795 | $197,025 | 0.02% |